Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment

Published on Jan 23, 2018in Journal of Gastroenterology6.132
· DOI :10.1007/S00535-018-1434-6
Hyun Woo Lee4
Estimated H-index: 4
(SCH: Soonchunhyang University),
Sung-Hoon Moon8
Estimated H-index: 8
(Sacred Heart Hospital)
+ 8 AuthorsSung Koo Lee69
Estimated H-index: 69
(UOU: University of Ulsan)
Background Type 1 autoimmune pancreatitis (AIP), as a pancreatic manifestation of IgG4-related disease, shows a favorable prognosis in the short term. However, disease relapse is common in long-term follow-up, despite a successful initial treatment response. This study aimed to identify the predictors of relapse and long-term outcomes in patients with type 1 AIP.
📖 Papers frequently viewed together
25 Authors (Phil A. Hart, ..., Suresh T. Chari)
343 Citations
37 Citations
85 Citations
#1Atsushi Masamune (Tohoku University)H-Index: 67
#2Isao NishimoriH-Index: 55
Last. Tooru Shimosegawa (Tohoku University)H-Index: 28
view all 29 authors...
Objective Corticosteroid has been established as the standard therapy for autoimmune pancreatitis (AIP), but the requirement for maintenance corticosteroid therapy is controversial. We conducted a randomised controlled trial to clarify the efficacy of maintenance corticosteroid therapy in patients with AIP. Design We conducted a multicentre, tertiary setting, randomised controlled trial. After the induction of remission with the initial oral prednisolone (PSL) treatment, maintenance therapy with...
88 CitationsSource
#1Kensuke Kubota (YCU: Yokohama City University)H-Index: 32
#2Terumi KamisawaH-Index: 77
Last. Tsutomu Chiba (Kyoto University)H-Index: 105
view all 26 authors...
Background The effect of maintenance steroid treatment (MST) in reducing the risk of relapse in patients with autoimmune pancreatitis (AIP) remains under debate. The aim of this study was to validate the effect of MST on AIP administered in accordance with the 2010 Japanese consensus guidelines.
37 CitationsSource
#1Kazuichi Okazaki (Kansai Medical University)H-Index: 85
#2Suresh T. Chari (Mayo Clinic)H-Index: 103
Last. Tooru Shimosegawa (Tohoku University)H-Index: 95
view all 11 authors...
Abstract Background and aims The International Consensus Diagnostic Criteria (ICDC) for AIP has proposed two distinctive type of AIP, type 1 and type 2, and enabled us first to differentiate two types of AIP each other. By initial steroid treatment for induction of remission, remission can be successfully induced in almost all subjects with type 1 and type 2 AIP. As relapse rate in type 1 AIP is significantly higher than in type 2 AIP, there has been ongoing debate on how to treat effectively re...
85 CitationsSource
#1Kyoko ShimizuH-Index: 22
#2Junko TaharaH-Index: 5
Last. Katsutoshi TokushigeH-Index: 40
view all 8 authors...
Autoimmune pancreatitis (AIP) responds well to steroid therapy but frequently relapses after discontinuing the steroid. It is difficult to know which cases are most likely to relapse. The aim of this study was to investigate the relation between the rate of decrease in serum IgG4 level after initial steroid therapy and a relapse.The subjects were 47 AIP patients who received steroid therapy. We calculated the difference between their serum IgG4 levels before and 2 months after the start of thera...
13 CitationsSource
#1Tsukasa Ikeura (Kansai Medical University)H-Index: 19
#2Hideaki Miyoshi (Kansai Medical University)H-Index: 14
Last. Kazuichi Okazaki (Kansai Medical University)H-Index: 85
view all 6 authors...
Autoimmune pancreatitis (AIP) has been considered a favorable-prognosis disease; however, currently, there is limited information on natural course of AIP during long-term follow-up. Recently published studies regarding the long-term outcomes of AIP has demonstrated the developments of pancreatic stone formation, exocrine insufficiency, and endocrine insufficiency are observed in 5%-41%, 34%-82%, and 38%-57% of patients having the disease. Furthermore, the incidence rate of developing pancreatic...
13 CitationsSource
#1Keita Kanai (RMIT: RMIT University)H-Index: 6
#2Masahiro Maruyama (RMIT: RMIT University)H-Index: 9
Last. Shigeyuki KawaH-Index: 67
view all 13 authors...
ObjectivesBecause several studies for autoimmune pancreatitis (AIP) have revealed pancreatic calcification resembling that in chronic pancreatitis (CP), we sought to clarify whether AIP could transform into chronic features similar to advanced CP with severe pancreatic dysfunction.MethodsPancreatic
9 CitationsSource
#1Venkata S. Katabathina (University of Texas Health Science Center at San Antonio)H-Index: 16
#2Suhare Khalil (University of Texas Health Science Center at San Antonio)H-Index: 1
Last. Srinivasa R. Prasad (University of Texas MD Anderson Cancer Center)H-Index: 44
view all 6 authors...
Abstract Immunoglobulin G4-related disease (IgG4-RD) is a novel, immune-mediated, multisystem disease characterized by the development of tumefactive lesions in multiple organs. IgG4-RD encompasses many fibroinflammatory diseases that had been thought to be confined to single organs. Delayed diagnosis or misdiagnosis as malignancies leading to aggressive treatment may be averted by identification of the multisystem nature of IgG4-RD. Most cases show exquisite response to steroid therapy; steroid...
14 CitationsSource
#1Emma L. Culver (John Radcliffe Hospital)H-Index: 17
#2Ross Sadler (Churchill Hospital)H-Index: 13
Last. Berne FerryH-Index: 28
view all 12 authors...
Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort
102 CitationsSource
#1Jorie Buijs (Erasmus University Medical Center)H-Index: 6
#2D.L. Cahen (UvA: University of Amsterdam)H-Index: 2
Last. Marco J. BrunoH-Index: 67
view all 13 authors...
textabstractObjective To evaluate the long-term outcome of autoimmune pancreatitis. Methods Patients with at least 2 years of follow-up were included. Information was collected regarding disease characteristics, treatment outcome, diagnosed malignancies, and mortality. In addition, pancreatic function and quality of life were assessed prospectively. Results 107 patients were included (87% men, 90% with type 1), with a median follow-up of 74 (interquartile range, 49-108) months. One third was ope...
25 CitationsSource
#1Tsukasa Ikeura (Kansai Medical University)H-Index: 19
#2Hideaki Miyoshi (Kansai Medical University)H-Index: 14
Last. Kazuichi Okazaki (Kansai Medical University)H-Index: 85
view all 10 authors...
Abstract Objectives Ordinary chronic pancreatitis (CP), such as alcoholic CP, is well established to have the increased risk for pancreatic cancer (PaC), nevertheless an association between autoimmune pancreatitis (AIP) and PaC is still unknown. The aims of this study are to examine the frequency of patients who developed PaC during follow-up after being diagnosed with type 1 AIP and to compare the incidence rate of PaC between patients with type 1 AIP and CP. Methods Sixty-three patients with t...
51 CitationsSource
Cited By30
#1Yoshiharu Masaki (Sapporo Medical University)H-Index: 7
#2Hiroshi Nakase (Sapporo Medical University)H-Index: 48
Last. Yuzo Kodama (Kobe University)H-Index: 35
view all 14 authors...
The effectiveness of azathioprine (AZA) in preventing relapse and maintaining autoimmune pancreatitis (AIP) remission has been reported; however, most of these studies are case series with no randomized control trials available in the literature. Therefore, this study performed a systematic review and meta-analysis of the existing literature on this subject to determine the clinical efficacy of AZA as maintenance therapy for AIP patients. A systematic search was performed to identify studies on ...
#1Hossein Haghbin (UT: University of Toledo)H-Index: 4
#2Justin Chuang (UT: University of Toledo)
Last. Muhammad Aziz (UT: University of Toledo)H-Index: 13
view all 6 authors...
There is conflicting evidence regarding autoimmune pancreatitis (AIP) association with pancreatic and non-pancreatic cancers. Literature lacks data on overall prevalence of malignancies in autoimmune pancreatitis. Given the lack of definite evidence, we aimed to pool and summarize data from available literature regarding prevalence of different malignancies in AIP. We conducted a systematic search of MEDLINE, EMBASE, Cochrane Register of Controlled Trials, and Web of Science through February 16,...
Last. Kam A. Newman (UCR: University of California, Riverside)H-Index: 9
view all 5 authors...
#1Ji Zongfei (Fudan University)H-Index: 2
#2Zhang Lijuan (Fudan University)H-Index: 2
Last. Chen Huiyong (Fudan University)H-Index: 2
view all 11 authors...
Objective To compare the clinical outcomes of patients with active immunoglobulin G (IgG) 4 related disease (IgG4-RD) receiving tocilizumab versus those receiving cyclophosphamide (CYC). Methods This IgG4-RD registry study was a prospective cohort study conducted among patients with active IgG4-RD hospitalized at Zhongshan Hospital, Fudan University. Patients who were treated with tocilizumab or CYC along with glucocorticoids (GCs) were enrolled. All participants were followed up at the hospital...
#1Ji Zongfei (Fudan University)H-Index: 2
#2Ma Lingying (Fudan University)H-Index: 1
Last. Jiang Lindi (Fudan University)H-Index: 2
view all 11 authors...
Patients with IgG4-related disease (IgG4-RD) suffer high relapse rates during long-term treatment, but factors that predict relapse outcomes are not well established. In the present study, we aimed to identify predictive factors for treatment resistance and disease relapse in a Chinese IgG4-RD cohort. This study enrolled 102 patients newly diagnosed with IgG4-RD. Disease prognosis was determined by evaluating disease activity and dosage of glucocorticoids. Predictive factors for refractory and r...
1 CitationsSource
#1Seung Bae Yoon (Catholic University of Korea)H-Index: 10
#2Sung-Hoon Moon (Hallym University)H-Index: 8
Last. Myung-Hwan Kim (UOU: University of Ulsan)H-Index: 89
view all 6 authors...
Abstract null null Background null The indications for maintenance glucocorticoid therapy (MGT) and its duration after initial remission of type 1 autoimmune pancreatitis (AIP) remain controversial. In contrast to the Japanese treatment protocol, the Mayo protocol does not recommend MGT after initial remission. This study aimed to evaluate the relapse rate in patients with type 1 AIP according to the duration of glucocorticoid therapy. null null null Methods null We conducted a systematic litera...
1 CitationsSource
#1Neng TangH-Index: 1
view all 8 authors...
#1Liang Zhu (Peking Union Medical College Hospital)H-Index: 7
#2Wen Zhang (Peking Union Medical College Hospital)H-Index: 27
Last. Yamin Lai (Peking Union Medical College Hospital)H-Index: 4
view all 10 authors...
OBJECTIVE. The purpose of this article was to evaluate the DWI features of autoimmune pancreatitis (AIP) at baseline, under treatment, and at relapse, and to assess the diagnostic accuracy of the ADC for determining disease activity. MATERIALS AND METHODS. This retrospective study was approved by the institutional review board. Sixty-two patients with AIP (48 at initial attack and 14 at relapse) underwent MRI with DWI (b = 0 and 800 s/mm2) at 3 T before receiving corticosteroid therapy (CST) and...
Objectives: IgG4-related disease (IgG4-RD) is a chronic fibro-inflammatory disorder affecting virtually any organ. Type 1 autoimmune (type 1 AIP) is its pancreatic manifestation. To date, steroids are considered the first-line pancreatitis treatment. The CD20-binding antibody rituximab (RTX) appears a promising steroid-sparing therapy, although long-term data are lacking. We aimed to bridge this gap with a cohort of IgG4-RD patients treated with RTX and to assess the potential value of the Respo...
1 CitationsSource